PathoGenetix
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
580 Pleasant St, Watertown, Massachusett...Phone Number
(617) 393-0194Website
www.pathogenetix.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PathoGenetix
PathoGenetix, Inc., is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The company's core Genome Sequence Scanning (GSS) technology isolates and analyzes DNA directly from an enriched biological sample-without the need for a cultured isolate-and provides results in just five hours, days faster than current methods. GSS has broad applicability in food safety, industrial microbiology, and clinical diagnostics and research. The first commercial GSS system will be available in 2014 for use in food safety testing and foodborne illness outbreak investigations.Explore more
PathoGenetix Org Chart
MF
Research Associate
SR
Staff Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PathoGenetix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if PathoGenetix has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if PathoGenetix is spiking on competitors!
Funding: Get notified immidiatlly once PathoGenetix has new funding data
Earning: See what the market has to say on PathoGenetix recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at PathoGenetix
Product Launch: Get notified when PathoGenetix launches new products
Website visits: Recent activity has been detected on your website
Click to see if PathoGenetix had a recent Job posting/layoffs
PathoGenetix, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at PathoGenetix
Find 2 more new buyers
Compare Similar Companies to PathoGenetix
Compare insights from companies similar to PathoGenetix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PathoGenetix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PathoGenetix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PathoGenetix.
PathoGenetix financials insights
Gather financial insights about PathoGenetix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$4.4M
2010
Debt
$1M
Unspecified
$1.3M
2011
Series B
$7.5M
2013
Series C
$10M
PathoGenetix Tech Stack
A closer look at the technologies used by PathoGenetix
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PathoGenetix
Sign Up For FreeTo access detailed company insights
PathoGenetix, Inc., is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The company's core Genome Sequence Scanning (GSS) technology... Read More
